Publications by authors named "Massimo Zani"

Claim this Profile
I
Identification of novel large genomic rearrangements by a computational algorithm of amplicon-based Next-Generation Sequencing data.
Arianna Nicolussi, Francesca Belardinilli, Valentina Silvestri, Yasaman Mahdavian, Virginia Valentini, Massimo Zani

PeerJ· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-generation sequencing of and genes for rapid detection of germline mutations in hereditary breast/ovarian cancer.
Arianna Nicolussi, Francesca Belardinilli, Yasaman Mahdavian, Valeria Colicchia, Sonia D'Inzeo, Massimo Zani

PeerJ· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coexistence of three EGFR mutations in an NSCLC patient: A brief report.
Francesca Belardinilli, Angela Gradilone, Alain Gelibter, Massimo Zani, Mario Occhipinti

Int J Biol Markers· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing the identification of risk-relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer families.
Anna Coppa, Arianna Nicolussi, Sonia D'Inzeo, Carlo Capalbo, Francesca Belardinilli, Massimo Zani

Cancer Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the Ion Torrent PGM sequencing for the prospective routine molecular diagnostic of colorectal cancer.
Francesca Belardinilli, Carlo Capalbo, Amelia Buffone, Marialaura Petroni, Valeria Colicchia, Massimo Zani

Clin Biochem· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of medulloblastoma in Fanconi Anemia: a novel mutation in the BRCA2 gene and SHH molecular subgroup.
Evelina Miele, Angela Mastronuzzi, Agnese Po, Andrea Carai, Vincenzo Alfano, Massimo Zani

Biomark Res· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel and recurrent BRCA2 mutations in Italian breast/ovarian cancer families widen the ovarian cancer cluster region boundaries to exons 13 and 14.
Anna Coppa, Amelia Buffone, Carlo Capalbo, Arianna Nicolussi, Sonia D'Inzeo, Massimo Zani

Breast Cancer Res Treat· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel human Smad4 mutation is involved in papillary thyroid carcinoma progression.
Sonia D'Inzeo, Arianna Nicolussi, Caterina Francesca Donini, Massimo Zani, Patrizia Mancini

Endocr Relat Cancer· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical classification of BRCA1 DNA missense variants: H1686Q is a novel pathogenic mutation occurring in the ontogenetically invariant THV motif of the N-terminal BRCT domain.
Giuseppe Giannini, Carlo Capalbo, Laura Ottini, Amelia Buffone, Laura De Marchis, Massimo Zani

J Clin Oncol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and/or ovarian cancer families.
Amelia Buffone, Carlo Capalbo, Enrico Ricevuto, Tina Sidoni, Laura Ottini, Massimo Zani

Breast Cancer Res Treat· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of mitochondrial biogenesis is a maladaptive mechanism in mitochondrial cardiomyopathies.
Mariangela Sebastiani, Carla Giordano, Chiara Nediani, Claudia Travaglini, Elisabetta Borchi, Massimo Zani

J Am Coll Cardiol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does the search for large genomic rearrangements impact BRCAPRO carrier prediction?
Carlo Capalbo, Amelia Buffone, Annarita Vestri, Enrico Ricevuto, Christian Rinaldi, Massimo Zani

J Clin Oncol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.
Giuseppe Giannini, Carlo Capalbo, Elisabetta Ristori, Enrico Ricevuto, Tina Sidoni, Massimo Zani

Breast Cancer Res Treat· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the accuracy of BRCA1/2 mutation prediction: validation of the novel country-customized IC software.
Carlo Capalbo, Enrico Ricevuto, Annarita Vestri, Tina Sidoni, Amelia Buffone, Massimo Zani

Eur J Hum Genet· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGF- and cell-cycle-regulated STAG1/PMEPA1/ERG1.2 belongs to a conserved gene family and is overexpressed and amplified in breast and ovarian cancer.
Giuseppe Giannini, Maria Irene Ambrosini, Lucia Di Marcotullio, Fabio Cerignoli, Massimo Zani

Mol Carcinog· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cloning of the mouse insulin receptor substrate-3 (mIRS-3) promoter, and its regulation by p53.
Salvatore Sciacchitano, Andrea Orecchio, Luca Lavra, Silvia Misiti, Anna Giacchini, Massimo Zani

Mol Endocrinol· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human MRE11 is inactivated in mismatch repair-deficient cancers.
Giuseppe Giannini, Elisabetta Ristori, Fabio Cerignoli, Christian Rinaldi, Massimo Zani

EMBO Rep· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis